Augmedix is a Digital Health startup founded in 2012, with its headquarters in the United States. The company's slogan, "See the Patient, Trust the Technology," reflects its mission to empower clinicians to engage with patients by freeing them from administrative tasks through ambient AI, data, and trust. Augmedix's platform leverages these technologies to convert natural conversations into structured medical notes, data, and point-of-care notifications, ultimately enhancing efficiency and clinical decision-making.
Notably, the company recently secured a $25.00M Post-IPO Equity investment on 15 November 2023. Although the investor information is not provided, this latest round of funding serves as a testament to Augmedix's continued growth and potential in the digital health and healthcare industries.
By collaborating with hospitals and health systems, Augmedix utilizes data from millions of interactions across various care settings to drive improvements in clinical, operational, and financial outcomes. This approach positions the company as a key player in the ongoing digital transformation of healthcare delivery, making it a compelling prospect for investors seeking opportunities in this rapidly evolving sector.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Post-IPO Equity | $25.00M | - | 15 Nov 2023 | |
Post-IPO Equity | $12.00M | 2 | 20 Apr 2023 | |
Post-IPO Equity | $6.50M | - | 02 Nov 2021 | |
Post-IPO Debt | $15.00M | 1 | 30 Mar 2021 | |
Private Equity Round | $25.00M | 3 | 06 Oct 2020 |